PD

Peter Dudek

President & Managing Partner, MRL Ventures Fund at Merck

Cambridge, Massachusetts

Invests in

Stages:

Sectors:

Boston / New England

Locations:

Cambridge, Massachusetts

Min Investment:
$15,000,000.00
Max Investment:
$20,000,000.00
Target Investment:
$17,500,000.00

Skills

Education

Uo
University of Oxford
(2009 - 2009)
SB
Saïd Business School, University of Oxford
(2007 - 2009)
Uo
Doctor of Philosophy
University of Geneva
(2000 - 2006)
TU
Bachelor of Science (Hons)
The University of British Columbia
(1998 - 2000)
CU
Associate of Science
Capilano University
(1996 - 1998)
WDHS
(1992 - 1996)

Lists including Peter

Based in UK

1884 people

Based in Boston & Cambridge

668 people

All Series A Investors

14748 people

All Seed Investors

19691 people

Investments

Carisma Therapeutics

Total Funding: $150M

Mozart Therapeutics

Total Funding: $55M

Xilio Therapeutics

Total Funding: $330M

Work Experience

M

2018

President & Managing Partner, MRL Ventures Fund
2021
Partner, MRL Ventures Fund
2018 - 2021

AO

2024

Board Observer
2024

TB

Therini Bio, Inc.

2024

Board Director
2024

I

2024

Board Observer
2024

I

2022

Board Director
2022

PT

Photys Therapeutics

2021

Board Observer
2021

TT

Tallac Therapeutics

2021

Board Director
2021

MT

Mozart Therapeutics, Inc

2020

Board Director
2020

AT

Ambagon Therapeutics

2020

Board Director
2020

CT

Caraway Therapeutics, Inc.

2021 - 2023

Board Director
2021 - 2023
Acquired by Merck.

Latest Articles

Medium•Jan. 2022

What is Pega and why you should learn it in 2024?

Developer Tools